Novel Antibacterial Agents / / Fiorella Meneghetti and Daniela Barlocco.

This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threa...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
TeilnehmendeR:
Place / Publishing House:Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (410 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603183104498
ctrlnum (CKB)5400000000043515
(NjHacI)995400000000043515
(EXLCZ)995400000000043515
collection bib_alma
record_format marc
spelling Meneghetti, Fiorella, author.
Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco.
Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (410 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threat to global health, and the twenty-two published articles here reported put in evidence that the discovery and development of new antibiotics are extremely challenging. The antimicrobial research covers a wide area, spanning from the design of new compounds, also supported by molecular modeling techniques, their synthesis and characterization, and biological tests. In this context, the current crisis caused by the COVID-19 pandemic, but also older threats, such as the human immunodeficiency virus or the hepatitis C virus, require greater attention than ever. The research works described in this book provide an extremely useful example of the results achieved in the field of antibacterial drug development. The search for new chemical entities was approached starting from both natural and synthetic compounds and addressing different targets. In addition, recent findings were presented and discussed highlighting the strategies to fight bacterial resistance. Detailed references to the state-of-the-art can be found in this book. We strongly encourage the wide group of readers to explore the book that we are presenting, to get inspired to develop new approaches for the diagnosis and treatment of antibacterial diseases, and to circumvent resistance issues.
Antibacterial agents.
3-0365-2861-X
Barlocco, Daniela, author.
language English
format eBook
author Meneghetti, Fiorella,
Barlocco, Daniela,
spellingShingle Meneghetti, Fiorella,
Barlocco, Daniela,
Novel Antibacterial Agents /
author_facet Meneghetti, Fiorella,
Barlocco, Daniela,
Barlocco, Daniela,
author_variant f m fm
d b db
author_role VerfasserIn
VerfasserIn
author2 Barlocco, Daniela,
author2_role TeilnehmendeR
author_sort Meneghetti, Fiorella,
title Novel Antibacterial Agents /
title_full Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco.
title_fullStr Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco.
title_full_unstemmed Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco.
title_auth Novel Antibacterial Agents /
title_new Novel Antibacterial Agents /
title_sort novel antibacterial agents /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (410 pages) : illustrations
isbn 3-0365-2861-X
callnumber-first R - Medicine
callnumber-subject RM - Therapeutics and Pharmacology
callnumber-label RM409
callnumber-sort RM 3409 M464 42022
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.92061
dewey-sort 3616.92061
dewey-raw 616.92061
dewey-search 616.92061
work_keys_str_mv AT meneghettifiorella novelantibacterialagents
AT barloccodaniela novelantibacterialagents
status_str n
ids_txt_mv (CKB)5400000000043515
(NjHacI)995400000000043515
(EXLCZ)995400000000043515
carrierType_str_mv cr
is_hierarchy_title Novel Antibacterial Agents /
author2_original_writing_str_mv noLinkedField
_version_ 1796653217886502912
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02563nam a2200289 i 4500</leader><controlfield tag="001">993603183104498</controlfield><controlfield tag="005">20230623142149.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230623s2022 sz a o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000043515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043515</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM409</subfield><subfield code="b">.M464 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.92061</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meneghetti, Fiorella,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Antibacterial Agents /</subfield><subfield code="c">Fiorella Meneghetti and Daniela Barlocco.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (410 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threat to global health, and the twenty-two published articles here reported put in evidence that the discovery and development of new antibiotics are extremely challenging. The antimicrobial research covers a wide area, spanning from the design of new compounds, also supported by molecular modeling techniques, their synthesis and characterization, and biological tests. In this context, the current crisis caused by the COVID-19 pandemic, but also older threats, such as the human immunodeficiency virus or the hepatitis C virus, require greater attention than ever. The research works described in this book provide an extremely useful example of the results achieved in the field of antibacterial drug development. The search for new chemical entities was approached starting from both natural and synthetic compounds and addressing different targets. In addition, recent findings were presented and discussed highlighting the strategies to fight bacterial resistance. Detailed references to the state-of-the-art can be found in this book. We strongly encourage the wide group of readers to explore the book that we are presenting, to get inspired to develop new approaches for the diagnosis and treatment of antibacterial diseases, and to circumvent resistance issues.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Antibacterial agents.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2861-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barlocco, Daniela,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:25:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337976160004498&amp;Force_direct=true</subfield><subfield code="Z">5337976160004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337976160004498</subfield></datafield></record></collection>